Antioxidant properties of the cerebrospinal fluid in neurodegenerative diseases

被引:0
|
作者
Kolmakova, T. S. [1 ]
Smirnova, O. B. [1 ]
Belyakova, E. I. [1 ]
机构
[1] S Fed Univ, Pedag Inst, Rostov Na Donu, Russia
关键词
catalase; SOD; free radical oxidation; antioxidant system; cerebrospinal fluid; brain; experimental allergic encephalomyelitis;
D O I
10.1134/S1819712410010083
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebrospinal fluid contains elements of the antioxidant system that are involved in the maintenance of homeostasis of the nervous tissue and its protection from free radical damage. Functional imbalances between antioxidant enzymes of the cerebrospinal fluid, such as superoxide dismutase (SOD) and catalase, have been revealed in schizophrenia, epilepsy, and multiple sclerosis. In neurological diseases SOD activity was higher, while catalase activity was lower as compared to the group of patients suffering from osteochondrosis, which was used for comparison. A decrease in the antioxidant capacity of the cerebrospinal fluid is associated with the accumulation of substances that induce oxidative stress in the brain. Incubation of patients' cerebrospinal fluid with homogenates of rat brain structures resulted in the activation of free radical processes. In canines, the development of experimental allergic encephalomyelitis (EAE) was accompanied by a decrease in the activity of enzymes of antioxidant (AO) defense as compared to intact animals. In animals that did not become ill the enzymatic activity was similar to the control. We hypothesized that the antioxidant system of the cerebrospinal fluid regulates the oxidative homeostasis of the brain. Inhibition of this system is one of the causes of oxidative stress in degenerative diseases of the nervous system.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 50 条
  • [41] Fluid Biomarkers in Neurodegenerative Diseases
    Maia, Luis F.
    MEDICINE, 2019, 98 (26)
  • [42] Natural Bioactive Products with Antioxidant Properties Useful in Neurodegenerative Diseases 2020
    Mendonca-Junior, Francisco Jaime Bezerra
    Scotti, Marcus Tullius
    Muratov, Eugene N.
    Scotti, Luciana
    Nayarisseri, Anuraj
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [43] Neurodegenerative Markers in Cerebrospinal Fluid in Parkinson Disease
    Vranova, Hana
    Mares, Jan
    Nevrly, Martin
    Kanovsky, Petr
    Stejskal, David
    NEUROLOGY, 2009, 72 (11) : A66 - A66
  • [44] Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study
    Kaipainen, Aku
    Jaaskelainen, Olli
    Liu, Yawu
    Haapalinna, Fanni
    Nykanen, Niko
    Vanninen, Ritva
    Koivisto, Anne M.
    Julkunen, Valtteri
    Remes, Anne M.
    Herukka, Sanna-Kaisa
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (03) : 751 - 765
  • [45] Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
    K. Minta
    G. Brinkmalm
    S. Janelidze
    S. Sjödin
    E. Portelius
    E. Stomrud
    H. Zetterberg
    K. Blennow
    O. Hansson
    U. Andreasson
    Alzheimer's Research & Therapy, 12
  • [46] Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
    Zanella, Isabella
    Blasco, Helene
    Filosto, Massimiliano
    Biasiotto, Giorgio
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [47] Cerebrospinal fluid from patients with neurodegenerative and neuroinflammatory diseases: no evidence for rat glial activation in vitro
    Wilms, H
    Rosenstiel, P
    Sievers, J
    Deuschl, G
    Lucius, R
    NEUROSCIENCE LETTERS, 2001, 314 (03) : 107 - 110
  • [48] Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
    Moren, Constanza
    deSouza, Ruth Mary
    Giraldo, Darly Milena
    Uff, Christopher
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [49] Characterization of cerebrospinal fluid biomarkers associated with neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys
    Robertson, Emma L.
    Boehnke, Susan E.
    Silva, Natalia M. Lyra E.
    Armitage-Brown, Brittney
    Winterborn, Andrew
    Cook, D. J.
    De Felice, Fernanda G.
    Munoz, Douglas P.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [50] Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
    Minta, K.
    Brinkmalm, G.
    Janelidze, S.
    Sjodin, S.
    Portelius, E.
    Stomrud, E.
    Zetterberg, H.
    Blennow, K.
    Hansson, O.
    Andreasson, U.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)